AccessibilityHelp
111 logo

111(NASDAQ) YI

Market Cap$16.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-98%
5 Year-94%
1 Year-32%
1 Month-14%
$3.07
-2.54%
-0.08Today
111 last closing stock price
MetricPriceDate
Last closeUSD 3.072026-10-22
111 stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.65%USD 3.092026-10-15
1 month-13.52%USD 3.552026-09-22
3 month-19.21%USD 3.802026-07-24
Year to date+19.92%USD 2.562025-12-31
1 year-32.23%USD 4.532025-10-22
3 year-86.23%USD 22.302023-10-23
5 year-94.49%USD 55.702021-10-22
Since inception-97.72%USD 138.002018-09-12

111 Financials at a Glance

Market Cap

$16.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥10.44B

Net Income (TTM)

-CN¥95.03M

EPS (TTM)

-$1.73

P/E Ratio

-1.82

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$3.07

Volume

14,397

Open

$3.15

Previous Close

$3.07

Daily Range

$3.07 - $3.18

52-Week Range

$2.48 - $11.17

Estimated Earnings Date

Nov 26, 2026

YI News

GettyImages-1222693662

This Is the Only Chinese Stock I Would Buy Right Now

Zhiyuan SunAug 20, 2021
GettyImages-510589412 (1)

3 Top Chinese Stocks to Watch in June

Zhiyuan SunJun 15, 2021
GettyImages-1267965670

Is 111 the Next Teladoc?

Adria CiminoFeb 12, 2021
telemedicine

Why 111 Stock Soared, Then Dropped Thursday

Howard SmithFeb 11, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 111

111, Inc. is a leading player in the Chinese healthcare sector, providing a comprehensive online-to-offline (O2O) ecosystem for medical and wellness products. Established in 2010 and headquartered in Shanghai, the company operates through both B2B and B2C channels, facilitating access to a wide range of healthcare solutions.

Products and Services
  • Prescription medications and over-the-counter drugs
  • Dietary supplements and personal care items
  • Online consultation and electronic prescription fulfillment
Growth Outlook
  • Revenue increased to CNY 2.3 billion in Q2 2026
  • Gross profit margin improved to 5.75% in the latest quarter
  • Strong inventory turnover ratio of 74.49 indicates efficient operations
Financial Highlights
  • Net income for Q2 2026 was CNY -39.13 million
  • Operating cash flow was CNY -11.44 million in Q2 2026
  • Current ratio stands at 1.07, indicating short-term financial stability
111, Inc. has established a robust operational framework that includes a diverse product catalog, catering to individual consumers and business partners alike. The company's online marketplace allows third-party vendors to supply pharmacies directly, enhancing its service offerings. Recent financial performance shows a notable increase in revenue, reflecting the growing demand for healthcare products in China. Despite challenges, the company maintains a solid current ratio, suggesting it can meet short-term obligations. The efficient inventory management, as evidenced by a high turnover ratio, further supports operational effectiveness. Overall, 111, Inc. is positioned to capitalize on the expanding healthcare market in China, making it an intriguing option for potential investors.
AI Generated • Oct 17, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

1,063

CEO

Jun Ling Liu, MBA

Website

www.111.com.cn

Headquarters

Shanghai, SH 201203, CN

YI Financials

Key Financial Metrics (TTM)

Gross Margin

5.73%

Operating Margin

-0.48%

Net Income Margin

-0.91%

Return on Equity

23.64%

Return on Capital

N/A

Return on Assets

-5.31%

Earnings Yield

-54.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.19M

Volume

14.40K

Avg. Volume

11.26K

Financials (TTM)

Gross Profit

CN¥598.89M

Operating Income

-CN¥50.15M

EBITDA

-CN¥28.91M

Operating Cash Flow

-CN¥35.21M

Capital Expenditure

-CN¥4.45M

Free Cash Flow

-CN¥39.66M

Cash & ST Invst.

CN¥381.26M

Total Debt

CN¥281.98M

111 Performance Analysis

111 annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 2,007,316,9274.2%
20232023-12-31CNY 2,109,819,1485.1%
20242024-12-31CNY 2,001,057,949-5.2%
20252025-12-31CNY 1,746,694,543-12.7%
111 sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-6.4%
Q42025-12-31-7.3%
Q12026-03-31-15.1%
Q22026-06-30-2.6%
111 annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY -7.43-40.7%
20232023-12-31CNY -6.57-11.5%
20242024-12-31CNY -1.05-84.1%
20252025-12-31CNY -1.061.4%
111 sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3033.0%
Q42025-12-31-21.3%
Q12026-03-31-130.8%
Q22026-06-30-4.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥2.30B

-28.3%

Gross Profit

CN¥132.27M

-28.6%

Gross Margin

5.75%

N/A

Market Cap

$16.33MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$15.37K

N/A

Employees

1,063

N/A

Net Income

-CN¥39.13M

-100.2%

EBITDA

-CN¥22.77M

-2013.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥381.26M

-14.8%

Total Debt

CN¥281.98M

+32.4%

Accounts Receivable

CN¥257.91M

-24.8%

Inventory

CN¥132.16M

-89.7%

Long Term Debt

CN¥21.99M

-48.8%

Short Term Debt

CN¥260.00M

+52.9%

Return on Assets

-5.31%

N/A

Return on Invested Capital

-27.30%

N/A

Free Cash Flow

-CN¥11.44M

+81.4%

Operating Cash Flow

-CN¥11.44M

+81.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DYAIDyadic International, Inc.
$0.40+0.50%
NMTCNeuroOne Medical Technologies Corporation
$0.98+7.54%
CELUCelularity Inc.
$1.05+2.94%
STRRStar Equity Holdings, Inc.
$9.70-0.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$7.88-14.81%
SPCXSpace Exploration Technologies
$144.75-9.14%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$82.11-20.47%
INTCIntel
$85.49-8.04%

Questions About YI

What is the current price of 111?

111 is trading at $3.07 per share.

What is the 52-week range for 111?

Over the past 52 weeks, 111 has traded between $2.48 and $11.17.

How much debt does 111 have?

As of the most recent reporting period, 111 reported total debt of CN¥41.56M.

How much cash does 111 have on hand?

111 reported CN¥47.32M in cash and cash equivalents in its most recent financial results.

What is 111’s dividend yield?

111 does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services